Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: SCOLR Pharma, Inc.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of SCOLR Pharma, Inc. since year 2005 are given in the first table. The second table lists detailed insider transactions reported by SCOLR Pharma, Inc. since 2005. The reporting company's ticker symbol is DDD. The reporting company's CIK number is 934936. The total value of stock buying during this period is $481,691. The total value of stock sales is $834,506. The total value of stock exercises is $243,201.

Figure 1. Monthly insider transaction values at SCOLR Pharma, Inc. (DDD) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $299,575

    $29,957

    $2,995

    $299

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at SCOLR Pharma, Inc. (DDD) in the past 24 months. See table 2 for insider transaction details.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $5.01

    $3.76

    $2.51

    $1.25



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for SCOLR Pharma, Inc. (DDD).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-05 2,500 2,662 0 0 0 0
2008-03 0 0 39,526 39,526 0 0
2008-01 0 0 0 0 20,000 20,000
2007-12 35,500 46,521 0 0 10,000 5,600
2007-05 5,000 12,012 0 0 0 0
2007-03 57,100 130,558 0 0 27,000 9,935
2007-02 0 0 0 0 50,000 52,500
2006-11 10,000 48,349 0 0 15,000 12,000
2006-08 0 0 54,000 261,856 50,000 52,500
2006-07 0 0 3,900 18,732 0 0
2006-06 7,500 38,000 62,700 299,575 0 0
2006-05 12,500 64,117 0 0 66,667 36,666
2006-04 0 0 0 0 60,000 54,000
2005-06 17,500 54,612 25,000 88,750 0 0
2005-04 22,000 84,860 32,500 126,067 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for SCOLR Pharma, Inc. (DDD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-05-07 Wilds Daniel O (Chief Executive Officer) Purchase 2,500 1.06 2,662
2008-03-11 Caudill Randall L W (Director) Sale 39,526 1.00 39,526
2008-01-22 Lucas Herbert L Jr (Director) Option Exercise 20,000 1.00 20,000
2007-12-17 Turner Stephen (Chief Technology Officer) Option Exercise 10,000 .56 5,600
2007-12-11 Levy Richard M (Chief Financial Officer) Purchase 2,000 1.21 2,420
2007-12-10 Mitchel Alan M (Sr. VP - Chief Legal Officer) Purchase 3,116 1.24 3,848
2007-12-10 Levy Richard M (Chief Financial Officer) Purchase 2,000 1.25 2,500
2007-12-07 Mitchel Alan M (Sr. VP - Chief Legal Officer) Purchase 4,384 1.31 5,743
2007-12-07 Levy Richard M (Chief Financial Officer) Purchase 2,000 1.34 2,680
2007-12-07 Taglich Michael N (Director) Purchase 10,000 1.32 13,200
2007-12-06 Wilds Daniel O (Chief Executive Officer) Purchase 10,000 1.34 13,450
2007-12-06 Levy Richard M (Chief Financial Officer) Purchase 2,000 1.34 2,680
2007-05-16 Wilds Daniel O (Director) Purchase 5,000 2.40 12,012
2007-03-20 Mitchel Alan M (Chief Legal Officer) Purchase 2,500 2.40 6,000
2007-03-19 Lucas Herbert L Jr (Director) Option Exercise 20,000 .32 6,400
2007-03-16 Turner Stephen (V.P., Chief Technical Officer) Option Exercise 7,000 .50 3,535
2007-03-16 Wilds Daniel O (Director) Purchase 10,000 2.24 22,400
2007-03-16 Levy Richard M (Chief Financial Officer) Purchase 14,600 2.23 32,558
2007-03-16 Taglich Michael N (Director) Purchase 30,000 2.32 69,600
2007-02-02 Fassihi Reza (Director) Option Exercise 50,000 1.05 52,500
2006-11-14 Taglich Michael N (Director) Purchase 5,000 4.90 24,500
2006-11-13 Wilds Daniel O (President and CEO) Purchase 5,000 4.77 23,849
2006-11-07 Lucas Herbert L Jr (Director) Option Exercise 15,000 .80 12,000
2006-08-28 Fassihi Reza (Director) Sale 4,000 4.97 19,880
2006-08-25 Fassihi Reza (Director) Sale 30,000 4.83 144,900
2006-08-24 Fassihi Reza (Director) Sale 8,000 4.83 38,650
2006-08-23 Fassihi Reza (Director) Sale 8,000 4.90 39,186
2006-08-08 Fassihi Reza (Director) Option Exercise 50,000 1.05 52,500
2006-07-05 Fassihi Reza (Director) Sale 3,900 4.80 18,732
2006-06-30 Fassihi Reza (Director) Sale 21,800 4.72 102,896
2006-06-29 Fassihi Reza (Director) Sale 22,900 4.78 109,347
2006-06-28 Fassihi Reza (Director) Sale 18,000 4.85 87,332
2006-06-13 Wilds Daniel O (Director) Purchase 1,000 4.93 4,930
2006-06-12 Wilds Daniel O (President and CEO) Purchase 1,500 4.98 7,470
2006-06-08 Taglich Michael N (Director) Purchase 5,000 5.12 25,600
2006-05-23 Fassihi Reza (Director) Option Exercise 66,667 .55 36,666
2006-05-19 Wilds Daniel O (President and CEO) Purchase 2,500 5.04 12,600
2006-05-16 Wilds Daniel O (President and CEO) Purchase 5,000 5.24 26,218
2006-05-16 Taglich Michael N (Director) Purchase 5,000 5.06 25,299
2006-04-19 Lucas Herbert L Jr (Director) Option Exercise 60,000 .90 54,000
2005-06-08 Wilds Daniel O (PRESIDENT AND CEO) Purchase 2,500 3.24 8,112
2005-06-06 Taglich Michael N (Director) Purchase 10,000 3.10 31,000
2005-06-01 Howard David T (Director) Sale 25,000 3.55 88,750
2005-04-08 Howard David T (Director) Sale 32,500 3.88 126,067
2005-04-08 Caudill Randall L W (Director) Purchase 1,000 3.85 3,850
2005-04-07 Wilds Daniel O (PRESIDENT AND CEO) Purchase 2,000 3.87 7,740
2005-04-07 Lucas Herbert L Jr (Director) Purchase 15,000 3.85 57,750
2005-04-07 Taglich Michael N (Director) Purchase 4,000 3.88 15,520

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of SCOLR Pharma, Inc. (symbol DDD, CIK number 934936) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.